Rhopressa Eye Drops, featuring 0.02% Netarsudil, is a once-daily ophthalmic solution designed to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. With a convenient 2.5 mL size, Rhopressa offers an innovative approach to managing eye pressure effectively.

Uses:

• IOP Reduction: For patients with open-angle glaucoma or ocular hypertension.
• Pressure Management: Helps prevent vision loss by controlling eye pressure.

Dosage: Instill one drop into the affected eye(s) once daily in the evening, as advised by your eye care professional.

CDC Guidelines:

• Maintain proper hand hygiene before use.
• Avoid contaminating the dropper tip by keeping it away from surfaces and the eye.

Details and Features:

• Once-Daily Administration: Simplifies treatment regimen for better compliance.
• Unique Mechanism: Utilizes Netarsudil for effective pressure reduction.
• Compact Size: 2.5 mL bottle for portability and ease of use.

Mechanism of Action: Netarsudil works by inhibiting Rho kinase, increasing the outflow of aqueous humor through the trabecular meshwork, thereby reducing intraocular pressure.

Directions:

1. Wash hands thoroughly.
2. Tilt head back and apply one drop into the affected eye(s) in the evening.
3. Close the bottle immediately after use.
4. Use consistently as prescribed.

Warnings:

• For ophthalmic use only.
• Do not touch the dropper tip to any surface to prevent contamination.
• Monitor for signs of allergic reaction; discontinue use and seek medical attention if necessary.
• Keep out of reach of children.

Side Effects: Possible side effects include:

• Conjunctival redness.
• Mild eye discomfort or irritation.
• Blurred vision immediately after application.
• If severe or persistent symptoms occur, consult your eye care professional promptly.

Rhopressa Eye Drops deliver targeted IOP reduction with a novel mechanism, providing a reliable option for glaucoma and ocular hypertension management.